Serum and Urinary Levels of Nitric Oxide and Uric Acid in Nigerian Children with Asthma

Main Article Content

Olatunbosun Arinola
Temiloluwa Olaiya
Victory Edem
Sheu Rahamon

Abstract

Background: Asthma is associated with increased production of reactive oxygen and nitrogen species and an alteration in the levels of antioxidants activities in the lung and blood. The increased production of the superoxide anion radicals contributes to airway remodelling and disease severity. Physiologically, the effect of increased free radical generation is eliminated by corresponding activities of a network of antioxidants. Presently, there is the dearth of information on the steady-state concentrations of nitric oxide (NO) and uric acid (UA) in children with asthma. The serum and urinary levels of NO and UA in children with asthma were thus determined in this study. Methodology: Fifty children consisting of 25 children with asthma and 25 age-matched apparently healthy children without asthma were enrolled into this study. Serum and urinary levels of NO and UA were determined using standard methods. Results: Serum levels of NO and UA were significantly higher while the urinary levels of NO and UA were significantly lower in children with asthma compared with the controls. There was no significant correlation between the serum ad urinary levels of NO and UA in children with asthma. Also, gender differences were not observed in the serum and urinary levels of NO and UA in children with asthma. Conclusion: Children with asthma have elevated serum levels of NO and UA accompanied with suboptimal urinary excretion. Therefore, children with asthma might benefit from routine renal function assessment owing to damages that can result from systemic accumulation of UA with concomitant reduction in its urinary excretion.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

Section
Articles

References

Abdulnaby, N. K., Sayed, A. O., and Shalaby, N. M. (2016). 'Predictive value of serum uric acid in hospitalized adolescents and adults with acute asthma', Ther Clin Risk Manag, 12: 1701-08.

Adeloye, D., Chan, K. Y., Rudan, I., and Campbell, H. (2013). 'An estimate of asthma prevalence in Africa: a systematic analysis', Croat Med J, 54: 519-31.

Al-Abdulla, N. O., Al Naama, L. M., and Hassan, M. K. (2010). 'Antioxidant status in acute asthmatic attack in children', J Pak Med Assoc, 60: 1023-7.

Ames, B. N., Cathcart, R., Schwiers, E., and Hochstein, P. (1981). 'Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis', Proceedings of the National Academy of Sciences of the United States of America, 78: 6858-62.

Anetor, J. I., Ajose, O. A., Ige, O., Oyeleye, A. O., and Ojo, P. O. (2003). 'Antioxidant status of adult Nigerian asthmatics: implications for prognosis', Nutr Health, 17: 221-9.

Arinola, Ganiyu O. (2020). 'Sputum, mononuclear cell lysate, and plasma levels of nitric oxide in Nigerian pulmonary tuberculosis patients before and during antituberculosis chemotherapy', The Egyptian Journal of Chest Diseases and Tuberculosis, 69: 6.

Baraldi, E., Ghiro, L., Piovan, V., Carraro, S., Ciabattoni, G., Barnes, P. J., et al. (2003). 'Increased exhaled 8-isoprostane in childhood asthma', Chest, 124: 25-31.

Batra, J., Pratap Singh, T., Mabalirajan, U., Sinha, A., Prasad, R., and Ghosh, B. (2007). 'Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels', Thorax, 62: 16-22.

Beckman, J. S., and Siedow, J. N. (1985). 'Bactericidal agents generated by the peroxidase-catalyzed oxidation of para-hydroquinones', J Biol Chem, 260: 14604-9.

Bobulescu, Ion Alexandru, and Moe, Orson W. (2012). 'Renal transport of uric acid: evolving concepts and uncertainties', Advances in chronic kidney disease, 19: 358-71.

Bowler, R. P. (2004). 'Oxidative stress in the pathogenesis of asthma', Curr Allergy Asthma Rep, 4: 116-22.

Brüne, B., von Knethen, A., and Sandau, K. B. (1998). 'Nitric oxide and its role in apoptosis', Eur J Pharmacol, 351: 261-72.

Busse, W. W., and Lemanske, R. F., Jr. (2001). 'Asthma', N Engl J Med, 344: 350-62.

Caramori, G., and Papi, A. (2004). 'Oxidants and asthma', Thorax, 59: 170-3.

Casiglia, E., Tikhonoff, V., Virdis, A., Masi, S., Barbagallo, C. M., Bombelli, M., et al. (2020). 'Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study', J Hypertens, 38: 412-19.

Cloutier, M. M., Dixon, A. E., Krishnan, J. A., Lemanske, R. F., Jr., Pace, W., and Schatz, M. (2020). 'Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program', Jama, 324: 2301-17.

Cluzel, M., Damon, M., Chanez, P., Bousquet, J., Crastes de Paulet, A., Michel, F. B., et al. (1987). 'Enhanced alveolar cell luminol-dependent chemiluminescence in asthma', J Allergy Clin Immunol, 80: 195-201.

Convento, M. S., Pessoa, E., Dalboni, M. A., Borges, F. T., and Schor, N. (2011). 'Pro-inflammatory and oxidative effects of noncrystalline uric acid in human mesangial cells: contribution to hyperuricemic glomerular damage', Urol Res, 39: 21-7.

Corradi, M., Folesani, G., Andreoli, R., Manini, P., Bodini, A., Piacentini, G., et al. (2003). 'Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation', Am J Respir Crit Care Med, 167: 395-9.

Csonka, C., Páli, T., Bencsik, P., Görbe, A., Ferdinandy, P., and Csont, T. (2015). 'Measurement of NO in biological samples', Br J Pharmacol, 172: 1620-32.

de Benedictis, F. M., and Attanasi, M. (2016). 'Asthma in childhood', Eur Respir Rev, 25: 41-7.

Dharmage, S. C., Perret, J. L., and Custovic, A. (2019). 'Epidemiology of Asthma in Children and Adults', Front Pediatr, 7: 246.

Diamant, Z., and Vijverberg, S. (2019). 'Toward clinically applicable biomarkers for asthma: An EAACI position paper', 74: 1835-51.

Dut, R., Dizdar, E. A., Birben, E., Sackesen, C., Soyer, O. U., Besler, T., et al. (2008). 'Oxidative stress and its determinants in the airways of children with asthma', Allergy, 63: 1605-9.

El Ridi, R., and Tallima, H. (2017). 'Physiological functions and pathogenic potential of uric acid: A review', J Adv Res, 8: 487-93.

Expert Panel Report 3. (2007). ''Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007'', J Allergy Clin Immunol, 120: S94-138.

Fahlen MT, Batuman V. . 2019. 'Uric Acid Nephropathy. ', Medscape, Accessed 16th March. https://emedicine.medscape.com/article/244255-overview.

Fujihara, C. K., De Nucci, G., and Zatz, R. (1995). 'Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy', J Am Soc Nephrol, 5: 1498-507.

Fujikawa, H., Sakamoto, Y., Masuda, N., Oniki, K., Kamei, S., Nohara, H., et al. (2020). 'Higher Blood Uric Acid in Female Humans and Mice as a Protective Factor against Pathophysiological Decline of Lung Function', Antioxidants (Basel), 9.

GBD 2016, Disease and Injury Incidence and Prevalence Collaborators. (2017). 'Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016'', Lancet, 390: 1211-59.

Glantzounis, G. K., Tsimoyiannis, E. C., Kappas, A. M., and Galaris, D. A. (2005). 'Uric acid and oxidative stress', Curr Pharm Des, 11: 4145-51.

Godard, P., Damon, M., Cluzel, M., Bousquet, J., Chanez, P., Crastes De Paulet, A., et al. (1987). '[Oxygen free radicals and bronchial asthma]', Allerg Immunol (Paris), 19: 15-8.

Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R. (1982). 'Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids', Anal Biochem, 126: 131-8.

Hoch, H. E., Houin, P. R., and Stillwell, P. C. (2019). 'Asthma in Children: A Brief Review for Primary Care Providers', Pediatr Ann, 48: e103-e09.

Holgate, S. T., and Polosa, R. (2006). 'The mechanisms, diagnosis, and management of severe asthma in adults', Lancet, 368: 780-93.

Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin, J. C., Smith, C. D., et al. (1992). 'Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase', Arch Biochem Biophys, 298: 431-7.

Kelm, M. (1999). 'Nitric oxide metabolism and breakdown', Biochim Biophys Acta, 1411: 273-89.

Kong, Ling-Fen, Li, Zhao-Hui, and Guo, Lu-Hong. (2002). 'Changes and Significance of Serum Nitric Oxide and Oxygen Free Radical in Children with Asthma or Mycoplasma Pneumonia', Chinese Journal of Contemporary Pediatrics, 4: 25-27.

Kool, M., Willart, M. A., van Nimwegen, M., Bergen, I., Pouliot, P., Virchow, J. C., et al. (2011). 'An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma', Immunity, 34: 527-40.

Kröncke, K. D., Fehsel, K., and Kolb-Bachofen, V. (1997). 'Nitric oxide: cytotoxicity versus cytoprotection--how, why, when, and where?', Nitric Oxide, 1: 107-20.

Li, L., Wan, C., and Wen, F. (2014). 'An unexpected role for serum uric acid as a biomarker for severity of asthma exacerbation', Asian Pac J Allergy Immunol, 32: 93-9.

Lima, W. G., Martins-Santos, M. E., and Chaves, V. E. (2015). 'Uric acid as a modulator of glucose and lipid metabolism', Biochimie, 116: 17-23.

Maarsingh, H., Zaagsma, J., and Meurs, H. (2009). 'Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives', Br J Pharmacol, 158: 652-64.

Maiuolo, J., Oppedisano, F., Gratteri, S., Muscoli, C., and Mollace, V. (2016). 'Regulation of uric acid metabolism and excretion', Int J Cardiol, 213: 8-14.

Martinez, F. D. (2006). 'Inhaled corticosteroids and asthma prevention', Lancet, 368: 708-10.

Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., and Tschopp, J. (2006). 'Gout-associated uric acid crystals activate the NALP3 inflammasome', Nature, 440: 237-41.

Masoli, M., Fabian, D., Holt, S., and Beasley, R. (2004). 'The global burden of asthma: executive summary of the GINA Dissemination Committee report', Allergy, 59: 469-78.

Mims, J. W. (2015). 'Asthma: definitions and pathophysiology', Int Forum Allergy Rhinol, 5 Suppl 1: S2-6.

Moncada, S., and Higgs, A. (1993). 'The L-arginine-nitric oxide pathway', N Engl J Med, 329: 2002-12.

Morris, C. R., Poljakovic, M., Lavrisha, L., Machado, L., Kuypers, F. A., and Morris, S. M., Jr. (2004). 'Decreased arginine bioavailability and increased serum arginase activity in asthma', Am J Respir Crit Care Med, 170: 148-53.

Nanda, A., and Wasan, A. N. (2020). 'Asthma in Adults', Med Clin North Am, 104: 95-108.

Pearce, N, and Strachan, D. (2011). 'The global asthma report 2011', The International Union against Tuberculosis and Lung Disease: Paris.

Prado, C. M., Martins, M. A., and Tibério, I. F. (2011). 'Nitric oxide in asthma physiopathology', ISRN Allergy, 2011: 832560.

Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991). 'Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide', Arch Biochem Biophys, 288: 481-7.

Ricciardolo, Fabio LM, Sterk, Peter J, Gaston, Benjamin, and Folkerts, Gert. (2004). 'Nitric oxide in health and disease of the respiratory system', Physiological reviews, 84: 731-65.

Sackesen, C., Ercan, H., Dizdar, E., Soyer, O., Gumus, P., Tosun, B. N., et al. (2008). 'A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma', J Allergy Clin Immunol, 122: 78-85.

Saleh, D., Ernst, P., Lim, S., Barnes, P. J., and Giaid, A. (1998). 'Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid', Faseb j, 12: 929-37.

Sanders, S. P. (1999). 'Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic?', Am J Respir Cell Mol Biol, 21: 147-9.

Sautin, Y. Y., and Johnson, R. J. (2008). 'Uric acid: the oxidant-antioxidant paradox', Nucleosides Nucleotides Nucleic Acids, 27: 608-19.

Schoettler, N., and Strek, M. E. (2020). 'Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine', Chest, 157: 516-28.

Shojaei-Far, Z., Razi, F., Bandarian, F., Rambod, C., and Qorbani, M. (2017). 'A Detailed Comparison of Morning and Random Urine Specimen Levels with 24 Hour Urinary Excretion Levels of Seven Biochemical Parameters with a Proposed Formula', Ann Clin Lab Sci, 47: 201-07.

Simoni, R. E., Gomes, L. N., Scalco, F. B., Oliveira, C. P., Aquino Neto, F. R., and de Oliveira, M. L. (2007). 'Uric acid changes in urine and plasma: an effective tool in screening for purine inborn errors of metabolism and other pathological conditions', J Inherit Metab Dis, 30: 295-309.

Trachtman, H. (2004). 'Nitric oxide and glomerulonephritis', Semin Nephrol, 24: 324-32.

Tümer, C., Bilgin, H. M., Obay, B. D., Diken, H., Atmaca, M., and Kelle, M. (2007). 'Effect of nitric oxide on phagocytic activity of lipopolysaccharide-induced macrophages: possible role of exogenous L-arginine', Cell Biol Int, 31: 565-9.

Uijen, AA, Schermer, TR, van den Hoogen, HJ, Mulder, J, Zantinge, EM, and Bottema, BJ. (2008). 'Prevalence of and health care consumption for asthma and COPD in relation to ethnicity', Nederlands tijdschrift voor geneeskunde, 152: 1157-63.

van Aalderen, Wim M. (2012). 'Childhood asthma: diagnosis and treatment', Scientifica, 2012.

Wang, Haixia, Jia, Yuanmin, Yi, Mo, Li, Yizhang, and Chen, Ou. (2020). 'High serum uric acid was a risk factor for incident asthma: an open cohort study', Risk Management and Healthcare Policy, 13: 2337.

Webb, J. L., Harvey, M. W., Holden, D. W., and Evans, T. J. (2001). 'Macrophage nitric oxide synthase associates with cortical actin but is not recruited to phagosomes', Infect Immun, 69: 6391-400.

Wennmalm, A., Benthin, G., Edlund, A., Jungersten, L., Kieler-Jensen, N., Lundin, S., et al. (1993). 'Metabolism and excretion of nitric oxide in humans. An experimental and clinical study', Circ Res, 73: 1121-7.

WHO, World Health Organization. 2021. 'Asthma ', World Health Organization, Accessed 25th June. who.int/news-room/fact-sheets/detail/asthma.

Wu, James T, and Wu, Lily L. (2007). 'Chronic systemic inflammation leading eventually to myocardial infarction, stroke, COPD, renal failure and cancer is induced by multiple risk factors', J Biomed Lab Sci, 19: 1.

Xiao, J., Fu, C., Zhang, X., Zhu, D., Chen, W., Lu, Y., et al. (2015). 'Soluble monosodium urate, but not its crystal, induces toll like receptor 4-dependent immune activation in renal mesangial cells', Mol Immunol, 66: 310-8.

Xiao, J., Zhang, X. L., Fu, C., Han, R., Chen, W., Lu, Y., et al. (2015). 'Soluble uric acid increases NALP3 inflammasome and interleukin-1? expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway', Int J Mol Med, 35: 1347-54.

Xu, X., Hu, J., Song, N., Chen, R., Zhang, T., and Ding, X. (2017). 'Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis', BMC Nephrol, 18: 27.

Zhu, L., Gunn, C., and Beckman, J. S. (1992). 'Bactericidal activity of peroxynitrite', Arch Biochem Biophys, 298: 452-7.